Search research articles
Contact Us
Filters
Showing results (11-20 of 43) with videos related to
Page
of 5
Sort By:
AIDS Research and Human Retroviruses
|
October 7, 2008
Can we predict neuropathy risk before stavudine prescription in a resource-limited setting?
Jacquita S Affandi, Patricia Price, Darma Imran, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde
|
October 3, 2015
Pharmacological treatment of painful HIV-associated sensory neuropathy
Prinisha Pillay, Antonia L Wadley, Catherine L Cherry, et al.
Ebiomedicine
|
May 24, 2016
Glucose Metabolism in T Cells and Monocytes: New Perspectives in HIV Pathogenesis
Clovis S Palmer, Catherine L Cherry, Isabel Sada-Ovalle, et al.
Journal of the Peripheral Nervous System : JPNS
|
October 7, 2019
Clinical diagnosis of sensory neuropathy in HIV patients treated with tenofovir: A 6-month follow-up study
Prinisha Pillay, Antonia L Wadley, Catherine L Cherry, et al.
AIDS and Behavior
|
July 16, 2017
Psychological Factors Associated With Painful Versus Non-Painful HIV-Associated Sensory Neuropathy
Prinisha Pillay, Antonia L Wadley, Catherine L Cherry, et al.
Mitochondrion
|
August 6, 2010
Mitochondrial dysfunction in CD4+ lymphocytes from stavudine-treated HIV patients
Lloyd Einsiedel, Catherine L Cherry, Freya L Sheeran, et al.
Journal of Cellular and Molecular Medicine
|
January 6, 2009
Measuring and monitoring apoptosis and drug toxicity in HIV patients by ligation-mediated polymerase chain reaction
David J Hooker, Paul R Gorry, Anne M Ellett, et al.
AIDS Research and Human Retroviruses
|
August 30, 2008
A report on the effect of commencing enfuvirtide on peripheral neuropathy
Catherine L Cherry, Alison J Duncan, Kathryn F Mackie, et al.
AIDS Research and Human Retroviruses
|
February 5, 2008
Cytokine genotype suggests a role for inflammation in nucleoside analog-associated sensory neuropathy (NRTI-SN) and predicts an individual's NRTI-SN risk
Catherine L Cherry, Ann Rosenow, Jacquita S Affandi, et al.
Current HIV Research
|
May 14, 2008
Phase 1 single dose studies to optimize the pharmacokinetics of DG17, a novel HIV-protease inhibitor pro-drug, using sodium bicarbonate and ritonavir
Catherine L Cherry, Jennifer F Hoy, James S Rowe, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 43) with videos related to
Sort By:
Page
of 5
AIDS Research and Human Retroviruses
|
October 7, 2008
Can we predict neuropathy risk before stavudine prescription in a resource-limited setting?
Jacquita S Affandi, Patricia Price, Darma Imran, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde
|
October 3, 2015
Pharmacological treatment of painful HIV-associated sensory neuropathy
Prinisha Pillay, Antonia L Wadley, Catherine L Cherry, et al.
Ebiomedicine
|
May 24, 2016
Glucose Metabolism in T Cells and Monocytes: New Perspectives in HIV Pathogenesis
Clovis S Palmer, Catherine L Cherry, Isabel Sada-Ovalle, et al.
Journal of the Peripheral Nervous System : JPNS
|
October 7, 2019
Clinical diagnosis of sensory neuropathy in HIV patients treated with tenofovir: A 6-month follow-up study
Prinisha Pillay, Antonia L Wadley, Catherine L Cherry, et al.
AIDS and Behavior
|
July 16, 2017
Psychological Factors Associated With Painful Versus Non-Painful HIV-Associated Sensory Neuropathy
Prinisha Pillay, Antonia L Wadley, Catherine L Cherry, et al.
Mitochondrion
|
August 6, 2010
Mitochondrial dysfunction in CD4+ lymphocytes from stavudine-treated HIV patients
Lloyd Einsiedel, Catherine L Cherry, Freya L Sheeran, et al.
Journal of Cellular and Molecular Medicine
|
January 6, 2009
Measuring and monitoring apoptosis and drug toxicity in HIV patients by ligation-mediated polymerase chain reaction
David J Hooker, Paul R Gorry, Anne M Ellett, et al.
AIDS Research and Human Retroviruses
|
August 30, 2008
A report on the effect of commencing enfuvirtide on peripheral neuropathy
Catherine L Cherry, Alison J Duncan, Kathryn F Mackie, et al.
AIDS Research and Human Retroviruses
|
February 5, 2008
Cytokine genotype suggests a role for inflammation in nucleoside analog-associated sensory neuropathy (NRTI-SN) and predicts an individual's NRTI-SN risk
Catherine L Cherry, Ann Rosenow, Jacquita S Affandi, et al.
Current HIV Research
|
May 14, 2008
Phase 1 single dose studies to optimize the pharmacokinetics of DG17, a novel HIV-protease inhibitor pro-drug, using sodium bicarbonate and ritonavir
Catherine L Cherry, Jennifer F Hoy, James S Rowe, et al.
Page
of 5